Invention Grant
- Patent Title: Alkylated piperazine compounds
- Patent Title (中): 烷基化哌嗪化合物
-
Application No.: US13667114Application Date: 2012-11-02
-
Publication No.: US08729072B2Publication Date: 2014-05-20
- Inventor: James John Crawford , Wendy B. Young
- Applicant: Genentech, Inc.
- Applicant Address: CH Basel
- Assignee: F. Hoffman-La Roche AG
- Current Assignee: F. Hoffman-La Roche AG
- Current Assignee Address: CH Basel
- Agency: Genetech, Inc.
- Agent Alex Andrus
- Main IPC: A61K31/5386
- IPC: A61K31/5386 ; A61K31/496 ; A61K31/4985 ; A61K31/5025 ; C07D498/08 ; C07D495/04 ; C07D487/04 ; C07D471/14

Abstract:
Alkylated piperazine compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
Public/Granted literature
- US20130116245A1 ALKYLATED PIPERAZINE COMPOUNDS Public/Granted day:2013-05-09
Information query
IPC分类: